Yes, MAM: how the cancer-related EMP3 protein became a regulator of erythropoiesis and the key protein underlying a new blood group system
By: M.D. Ilsley, J.R. Storry and M.L. Olsson
Authors
M.D. Ilsley
Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Lund, Sweden
J.R. Storry
Experimental Transfusion Medicine, Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Technical Director, Immunohematology, Department of Clinical Immunology and Transfusion Medicine, Office of Medical Services, Lund
M.L. Olsson
Transfusion Medicine, Deputy Dean, Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Medical Director of the Nordic Reference Laboratory for Genomic Blood Group Typing, Department of Clinical Immunology and Transfusion Medicine, Office of Medical Services, Lund
DOI: https://doi.org/10.21307/immunohematology-2022-055 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 130 - 136
Published on: Dec 28, 2022
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2022 M.D. Ilsley, J.R. Storry, M.L. Olsson, published by American National Red Cross
This work is licensed under the Creative Commons Attribution 4.0 License.